On Tuesday, Heron Therapeutics Inc (NASDAQ: HRTX) opened lower -0.56% from the last session, before settling in for the closing price of $1.78. Price fluctuations for HRTX have ranged from $0.50 to $3.93 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 17.85%. Company’s average yearly earnings per share was noted 84.30% at the time writing. With a float of $144.07 million, this company’s outstanding shares have now reached $150.29 million.
The extent of productivity of a business whose workforce counts for 126 workers is very important to gauge. In terms of profitability, gross margin is 65.49%, operating margin of -34.02%, and the pretax margin is -35.29%.
Heron Therapeutics Inc (HRTX) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Heron Therapeutics Inc is 5.01%, while institutional ownership is 81.13%. The most recent insider transaction that took place on Nov 17 ’23, was worth 27,250. In this transaction EVP, Chief Development Officer of this company bought 25,000 shares at a rate of $1.09, taking the stock ownership to the 79,000 shares. Before that another transaction happened on Nov 16 ’23, when Company’s EVP, Chief Development Officer bought 50,000 for $0.94, making the entire transaction worth $46,995. This insider now owns 54,000 shares in total.
Heron Therapeutics Inc (HRTX) Latest Financial update
If we go through the results of last quarter, which was made public on 6/30/2024, the company posted -0.17 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.29) by 0.12. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.03 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 84.30% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 47.50% during the next five years compared to 20.01% growth over the previous five years of trading.
Heron Therapeutics Inc (NASDAQ: HRTX) Trading Performance Indicators
Check out the current performance indicators for Heron Therapeutics Inc (HRTX). In the past quarter, the stock posted a quick ratio of 1.85. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.97.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.33, a number that is poised to hit -0.04 in the next quarter and is forecasted to reach -0.03 in one year’s time.
Technical Analysis of Heron Therapeutics Inc (HRTX)
The latest stats from [Heron Therapeutics Inc, HRTX] show that its last 5-days average volume of 1.11 million was inferior to 2.4 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 25.99%. Additionally, its Average True Range was 0.12.
During the past 100 days, Heron Therapeutics Inc’s (HRTX) raw stochastic average was set at 14.78%, which indicates a significant decrease from 23.73% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 48.75% in the past 14 days, which was lower than the 85.61% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.8776, while its 200-day Moving Average is $2.5951. Now, the first resistance to watch is $1.7933. This is followed by the second major resistance level at $1.8167. The third major resistance level sits at $1.8633. If the price goes on to break the first support level at $1.7233, it is likely to go to the next support level at $1.6767. The third support level lies at $1.6533 if the price breaches the second support level.
Heron Therapeutics Inc (NASDAQ: HRTX) Key Stats
There are currently 151,668K shares outstanding in the company with a market cap of 268.45 million. Presently, the company’s annual sales total 127,040 K according to its annual income of -110,560 K. Last quarter, the company’s sales amounted to 36,020 K and its income totaled -9,240 K.
